Exor press release – announcement of the share buyback program in the second tranche

Amsterdam, 12 August 2024

EXOR NV ANNOUNCES LAUNCH
SECOND TRANCHE OF THE SHARE BUY-BACK PROGRAM

Exor NV (the “Company”) announces today its intention to continue the share buy-back program announced on September 13, 2023 (the “Program”) for the remaining amount of up to EUR 250 million of ordinary shares to reduce Exor’s share capital as announced on September 13, 2023.

The Company will commence a second tranche of purchases of up to €125 million on August 12, 2024, which is expected to be completed by November 2024 or earlier if the maximum amount is reached (the “Second Tranche”). The Second Tranche follows the first tranche of purchases of up to €125 million announced on April 15, 2024 and completed on July 1, 2024.

The second tranche will be executed in accordance with applicable rules and regulations, including Market Abuse Regulation 596/2014 and Commission Delegated Regulation (EU) 2016/1052. It will be executed pursuant to a discretionary repurchase agreement with a lead financial institution in accordance with the Safe Harbor provisions for share repurchases. As the second tranche will be managed by a financial institution within pre-defined execution parameters, transactions may be executed during closed periods.

The purchases will be made pursuant to the authorisation granted to the Board by the general meeting of shareholders of the Company (the “GM”) at its annual general meeting held on 31 May 2023, valid until 30 November 2024 (inclusive), and pursuant to the continuing authorisation granted by the GM at its annual general meeting held on 28 May 2024. The shares that are repurchased will be cancelled subject to the consent of the relevant board members and shareholders.

The Company will post progress updates on its website weekly in accordance with applicable laws. The Company is not obligated to implement the Program and it may be suspended, terminated or modified at any time, for any reason, in accordance with applicable laws and regulations.

The Company currently has 6,124,471 common shares outstanding.

Attachment